Reaction
Cardiac Amyloidosis reporting signals
As of the last recalculation, Cardiac Amyloidosis appears in 1,073 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is TAFAMIDIS (PRR 434.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tafamidis | 212 | 434.9 | 442.9 |
| Eplerenone | 51 | 81.1 | 81.4 |
| Metolazone | 18 | 31.6 | 31.6 |
| Bortezomib | 128 | 31.4 | 31.4 |
| Apixaban | 91 | 28.7 | 28.8 |
| Daratumumab | 55 | 28.1 | 28.1 |
| Torsemide | 41 | 24.9 | 25.0 |
| Amiodarone Hydrochloride | 14 | 24.5 | 24.6 |
| Dapagliflozin | 38 | 24.3 | 24.3 |
| Bumetanide | 28 | 21.1 | 21.1 |
| Febuxostat Tablets 40 Mg | 10 | 19.2 | 19.3 |
| Febuxostat Tablets 80 Mg | 10 | 19.2 | 19.3 |
| Tolvaptan | 14 | 18.9 | 18.9 |
| Carfilzomib | 23 | 16.1 | 16.1 |
| Ixazomib | 23 | 15.8 | 15.8 |
| Thalidomide | 28 | 15.2 | 15.2 |
| Sotalol Hydrochloride | 12 | 14.1 | 14.2 |
| Melphalan | 15 | 13.0 | 13.0 |
| Febuxostat | 11 | 12.9 | 12.9 |
| Canakinumab | 7 | 12.6 | 12.6 |
| Melphalan Hydrochloride | 16 | 12.6 | 12.6 |
| Tamsulosin Hydrochloride | 13 | 12.5 | 12.5 |
| Dexamethasone 1.5 Mg | 160 | 12.3 | 12.3 |
| Dexamethasone | 160 | 12.1 | 12.1 |
| Empagliflozin | 40 | 11.9 | 11.9 |
| Dofetilide | 6 | 11.1 | 11.1 |
| Oseltamivir | 3 | 7.3 | 7.3 |
| Sacubitril And Valsartan | 42 | 7.3 | 7.3 |
| Lenalidomide | 137 | 7.1 | 7.1 |
| Acalabrutinib | 4 | 6.4 | 6.4 |
| Pomalidomide | 23 | 4.4 | 4.4 |
| Droxidopa | 4 | 3.6 | 3.6 |